NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/30/2024
Back to search
Official data from USPTO
AMPLIMUNE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
08/30/2024
Trademark type
Word
Nice classes
5
Filing date
04/29/2015
Registration date
01/23/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/30/2024
Last transaction
08/30/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Belleville, Ontario, CA
Examiner
BRODY,DANIEL S
Current location
Historical data usage
Holders and representatives
Holders
Novavive Inc.
Representatives
Stephen R. Barrese Dilworth & Barrese Llp
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
An immunotherapeutic agent for the treatment of ruminantsfor the treatment of neonatal and juvenile diseases; An immunotherapeutic agent for the treatment of cattle and other ruminantsfor the treatment of diarrhea; An immunotherapeutic agent for the treatment of cattle and other ruminantsfor the treatment of diarrhea in neonates
Publications
History of USPTO decisions and trademark events.
43 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/30/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
08/29/2024
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
08/08/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/25/2024
E815
TEAS SECTION 8 & 15 RECEIVED
01/11/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/23/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/23/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/07/2017
PUBO
PUBLISHED FOR OPPOSITION
11/07/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/18/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/03/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/02/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/02/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/02/2017
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/20/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/28/2017
GNSL
LETTER OF SUSPENSION E-MAILED
08/28/2017
CNSL
SUSPENSION LETTER WRITTEN
08/28/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/23/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/23/2017
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/17/2017
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
02/26/2017
GNSI
INQUIRY TO SUSPENSION E-MAILED
02/26/2017
CNSI
SUSPENSION INQUIRY WRITTEN
02/26/2017
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
02/24/2017
DOCK
ASSIGNED TO EXAMINER
11/15/2016
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/19/2016
GNSL
LETTER OF SUSPENSION E-MAILED
08/19/2016
CNSL
SUSPENSION LETTER WRITTEN
08/19/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/15/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/15/2016
ALIE
ASSIGNED TO LIE
08/12/2016
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/03/2016
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
02/12/2016
GNSI
INQUIRY TO SUSPENSION E-MAILED
02/12/2016
CNSI
SUSPENSION INQUIRY WRITTEN
02/12/2016
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/12/2015
GNSL
LETTER OF SUSPENSION E-MAILED
08/12/2015
CNSL
SUSPENSION LETTER WRITTEN
08/12/2015
DOCK
ASSIGNED TO EXAMINER
08/10/2015
MPMK
NOTICE OF PSEUDO MARK E-MAILED
05/12/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/11/2015
Continuous trademark protection
Get notified about every new filing that threatens AMPLIMUNE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.